Dare Bioscience, Inc. (DARE) vs Karyopharm Therapeutics Inc. (KPTI)
A side-by-side comparison of Dare Bioscience, Inc. and Karyopharm Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DARE
Dare Bioscience, Inc.
$0.84HealthcareDelayed quote: Oct 6, 2026, 11:43 AM EDT
KPTI
Karyopharm Therapeutics Inc.
$0.66HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
Total return — DARE vs KPTI
growth of $100 · dividends reinvested · last 10yDARE -99.3% (-39.1%/yr)KPTI -99.5% (-41.7%/yr)DARE compounded faster over this window
DARE KPTI
DARE vs KPTI: by the numbers
- •KPTI is the larger company ($15M vs $13M market cap).
- •Both run net losses; KPTI's is the smaller (-153.28% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | DARE | KPTI |
|---|---|---|
| P/S ratio | 9.18 | 0.10 |
Profitability
| Metric | DARE | KPTI |
|---|---|---|
| Gross margin | -137.55% | 95.88% |
| Operating margin | -1315.51% | -56.17% |
| Net margin | -804.37% | -153.28% |
| ROIC | -203.50% | N/A |
Growth (annualized)
| Metric | DARE | KPTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.47% |
| Total return CAGR (5Y) | -46.35% | -62.18% |
Frequently asked
- How have DARE and KPTI total returns compared?
- Over the past 10 years, DARE delivered -39.10% and KPTI delivered -41.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.